A randomized, controlled trial to investigate the effect of ciclesonide and beclomethasone dipropionate on eye lens opacity

Journal of Asthma

Volumn 45, Issue 10, 2008, Pages 893-902

  Chylack Jr , Leo T ^a,b,e   Gross, Gary N ^c   Pedinoff, Andrew ^d   Abdullah, I ^e   Andrews, C ^e   Antczak, A ^e   Baker, J ^e   Banov, C ^e   Bardelas, J ^e   Basheda, S ^e   Bateman, E ^e   Bensch, G ^e   Berger, W ^e   Berman, G ^e   Bernstein, D ^e   Bester, A ^e   Blumberg, M ^e   Bodzenta Lukaszyk, A ^e   Brazinsky, S ^e   Busse, W ^e   Campbell, E ^e   Charous, B ^e   Cohen, S ^e   Condemi, J ^e   Cook, D ^e   Corren, J ^e   Craig, J ^e   Daul, C ^e   DeGraff, A ^e   Drehobl, M ^e   Dumont, D ^e   Dymek, A ^e   Elkayam, D ^e   Engelbrecht, I ^e   Falliers, C ^e   Filley, W ^e   Fineman, S ^e   Ford, L ^e   Friedman, B ^e   Fouche, L ^e   Gamel, W ^e   Gaona Jr , R ^e   Gillman, S ^e   Gilman, R ^e   Goldberg, P ^e   Goldsobel, A ^e   Goldstein, S ^e   Gower, R ^e   Graham, Y ^e   Greos, L ^e   Grzelewska Rzymowska, I ^e   Hampel Jr , F ^e   Harris, J ^e   Harris, D ^e   Hill, D ^e   Horner, S ^e   Ismail, M ^e   Jacobson, K ^e   Journeay, G ^e   Kaiser, H ^e   Kerwin, E ^e   Kowalski, M ^e   LaForce, C ^e   Lampl, K ^e   LeDoux, E ^e   Leflein, J ^e   Levy, R ^e   Lindley, M ^e   Lowdermilk, T ^e   Lumry, W ^e   Majorek Olechowska, B ^e   Manjra, A ^e   Mansfield, L ^e   Meadows, J ^e   Meltzer, S ^e   Miller, S ^e   Murphy, K ^e   Nadeemullah, M ^e   Nathan, R ^e   Nayak, A ^e   Noonan, M ^e   O'Brien, J ^e   Olson, G ^e   Patel, S ^e   Pearlman, D ^e   Pfuetze, B ^e   Pleskow, W ^e   Prenner, B ^e   Raphael, G ^e   Ratner, P ^e   Rupp, N ^e   Saff, R ^e   Sahn, S ^e   Schenkel, E ^e   Segal, A ^e   Segall, N ^e   Sellman, R ^e   Settipane, R ^e   Sheffer, A ^e   Sher, L ^e   Sher, E ^e   Sinclair, W ^e   Slominski, J ^e   Smith, C ^e,e   Sotomayor, J ^e   Spangenthal, S ^e   Spector, S ^e   Sveum, R ^e   Tarpay, M ^e   Tilles, S ^e   Wachtel, A ^e   Wald, J ^e   Weakley, S ^e   Weiler, J ^e   Weinstein, S ^e   Welch, M ^e   Wenzel, S ^e   Williams, K ^e   Winder, J ^e   Yoon, Y ^e   Ziering, R ^e   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Pharmaceutical Research and Consulting Inc   (United States)

^d Princeton Center for Clinical Research   (United States)

^e NONE

Author keywords

Asthma; Beclomethasone dipropionate; Cataract; Ciclesonide; Lenticular opacities

Indexed keywords

BECLOMETASONE DIPROPIONATE; CICLESONIDE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASTHMA; CANDIDIASIS; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DYSPHONIA; FEMALE; GLAUCOMA; HUMAN; HYPERTENSION; LENS OPACITIES CLASSIFICATION SYSTEM III; MAJOR CLINICAL STUDY; MALE; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RETINA HEMORRHAGE; RISK ASSESSMENT; SIDE EFFECT; THRUSH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ALLERGIC AGENTS; ASTHMA; BECLOMETHASONE; CATARACT; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; LENS, CRYSTALLINE; MALE; MIDDLE AGED; PREGNENEDIONES; YOUNG ADULT;

EID: 57749186647     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900802353636     Document Type: Article

References (31)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Available from: www.ginasthma.org., 2007.
2. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Programme. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Available from: http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.pdf. 2007. Accessed July 2008.
3. Allen DB. Inhaled steroids for children: effects on growth, bone, and adrenal function. Endocrinol Metab Clin North Am 2005; 34:555-64, viii.
4. Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 2003; 112:S1-40.
5. Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med 2006; 100:1307-1317.
6. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med 1999; 159:941-955.
7. Ernst P, Baltzan M, Deschenes J, Suissa S. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J 2006; 27:1168-1174.
8. Nootheti S, Bielory L. Risk of cataracts and glaucoma with inhaled steroid use in children. Compr Ophthalmol Update 2006; 7:31-39.
9. Uboweja A, Malhotra S, Pandhi P. Effect of inhaled corticosteroids on risk of development of cataract: a meta-analysis. Fundam Clin Pharmacol 2006; 20:305-309.
10. Chylack LT, Jr., Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993; 111:831-836.
11. Karbassi M, Khu PM, Singer DM, Chylack LT, Jr. Evaluation of lens opacities classification system III applied at the slitlamp. Optom Vis Sci 1993; 70:923-928.
12. Bailey IL, Lovie JE. The design and use of a new near-vision chart. Am J Optom Physiol Opt 1980; 57:378-387.
13. Ottar WL. Tonometry. Insight 1998; 23:11-17.
14. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152:1107-1136.
15. Nayak A, Nathan R, Williams J, Kundu S, Lloyd M, Banerji D. Ciclesonide does not suppress the hypothalamic-pituitary-adrenal axis function in patients with severe persistent asthma: results of a long-term study. Ann Allergy Asthma Immunol 2005; 94:170 (Abstract P64).
16. Leske MC, Chylack LT, Jr., Wu SY, Schoenfeld E, He Q, Friend J, et al. Incidence and progression of nuclear opacities in the Longitudinal Study of Cataract. Ophthalmology 1996; 103:705-712.
17. Leske MC, Chylack LT, Jr., He Q, Wu SY, Schoenfeld E, Friend J, et al. Incidence and progression of cortical and posterior subcapsular opacities: the Longitudinal Study of Cataract. The LSC Group. Ophthalmology 1997; 104:1987-1993.
18. Leske MC, Chylack LT, Jr., He Q, Wu SY, Schoenfeld E, Friend J, et al. Risk factors for nuclear opalescence in a longitudinal study. LSC Group. Longitudinal Study of Cataract. Am J Epidemiol 1998; 147:36-41.
19. Srinivasan M, Rahmathullah R, Blair CR, Murphy AC, Beck RW, Wilkins JH, et al. Cataract progression in India. Br J Ophthalmol 1997; 81:896-900.
20. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers. Chest 2002; 122:510-516.
21. Leach CL, Bethke TD, Boudreau RJ, Hasselquist BE, Drollmann A, Davidson P, et al. Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers. J Aerosol Med 2006; 19:117-126.
22. Davies RJ, Stampone P, O'Connor BJ. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose. Respir Med 1998; 92 Suppl A:23-31.
23. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997; 337:8-14.
24. Garbe E, Suissa S, LeLorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 1998; 280:539-543.
25. Smeeth L, Boulis M, Hubbard R, Fletcher AE. A population based case-control study of cataract and inhaled corticosteroids. Br J Ophthalmol 2003; 87:1247-1251.
26. Leske MC, Wu SY, Nemesure B, Hennis A. Risk factors for incident nuclear opacities. Ophthalmology 2002; 109:1303-1308.
27. Chylack LT, Jr. Cataracts and inhaled corticosteroids. N Engl J Med 1997; 337:46-48.
28. Hodge WG, Whitcher JP, Satariano W. Risk factors for age-related cataracts. Epidemiol Rev 1995; 17:336-346.
29. Hennis A, Wu SY, Nemesure B, Leske MC. Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol 2004; 122:525-530.
30. Langdon CG, Adler M, Mehra S, Alexander M, Drollmann A. Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma. Respir Med 2005; 99:1275-1285.
31. Chapman KR, Patel P, D'Urzo AD, Alexander M, Mehra S, Oedekoven C, et al. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Allergy 2005; 60:330-337.